Cardiac fibrosis in myocardial infarction—from repair and remodeling to regeneration
暂无分享,去创建一个
[1] Kenneth L. Jones,et al. High-efficiency reprogramming of fibroblasts into cardiomyocytes requires suppression of pro-fibrotic signalling , 2015, Nature Communications.
[2] A. Leask. Getting to the heart of the matter: new insights into cardiac fibrosis. , 2015, Circulation research.
[3] E. Olson,et al. A Dynamic Notch Injury Response Activates Epicardium and Contributes to Fibrosis Repair , 2011, Circulation research.
[4] N. Frangogiannis,et al. Fibroblasts in myocardial infarction: a role in inflammation and repair. , 2014, Journal of molecular and cellular cardiology.
[5] D. Lindemann,et al. A new approach to transcription factor screening for reprogramming of fibroblasts to cardiomyocyte-like cells. , 2012, Journal of molecular and cellular cardiology.
[6] R. Markwald,et al. Recruitment of New Cells into the Postnatal Heart , 2006, Annals of the New York Academy of Sciences.
[7] Johan Verjans,et al. Myocardial remodeling after infarction: the role of myofibroblasts , 2010, Nature Reviews Cardiology.
[8] D. Srivastava,et al. Direct reprogramming of fibroblasts into cardiomyocytes for cardiac regenerative medicine. , 2015, Circulation journal : official journal of the Japanese Circulation Society.
[9] B. Ebert,et al. Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis. , 2015, Cell stem cell.
[10] A. Hoes,et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.
[11] J. Balligand,et al. HMGCoA reductase inhibition reverses myocardial fibrosis and diastolic dysfunction through AMP-activated protein kinase activation in a mouse model of metabolic syndrome. , 2013, Cardiovascular research.
[12] N. Bursac,et al. Stoichiometry of Gata4, Mef2c, and Tbx5 Influences the Efficiency and Quality of Induced Cardiac Myocyte Reprogramming , 2015, Circulation research.
[13] N. Sharpe,et al. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. , 2000, Circulation.
[14] M. Hiroe,et al. Tenascin-C may aggravate left ventricular remodeling and function after myocardial infarction in mice. , 2010, American journal of physiology. Heart and circulatory physiology.
[15] R. Graham,et al. Cardiac Regeneration Therapies - Targeting Neuregulin 1 Signalling. , 2016, Heart, lung & circulation.
[16] Ofer Binah,et al. Cardiomyocytes derived from human embryonic and induced pluripotent stem cells: comparative ultrastructure , 2011, Journal of cellular and molecular medicine.
[17] F. Rodríguez-Pascual,et al. The profibrotic role of endothelin-1: is the door still open for the treatment of fibrotic diseases? , 2014, Life sciences.
[18] F. Slack,et al. The let-7 family of microRNAs. , 2008, Trends in cell biology.
[19] Gang Wang,et al. Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy , 2011, Nature Cell Biology.
[20] G. Fonarow,et al. Epidemiology and risk profile of heart failure , 2011, Nature Reviews Cardiology.
[21] N. Turner,et al. Cardiac fibroblasts: at the heart of myocardial remodeling. , 2009, Pharmacology & therapeutics.
[22] I. Karakikes,et al. Therapeutic Cardiac‐Targeted Delivery of miR‐1 Reverses Pressure Overload–Induced Cardiac Hypertrophy and Attenuates Pathological Remodeling , 2013, Journal of the American Heart Association.
[23] B. Hinz,et al. The Single-Molecule Mechanics of the Latent TGF-β1 Complex , 2011, Current Biology.
[24] N. Frangogiannis,et al. IL-1 Induces Proinflammatory Leukocyte Infiltration and Regulates Fibroblast Phenotype in the Infarcted Myocardium , 2013, The Journal of Immunology.
[25] J. Burnett,et al. Brain Natriuretic Peptide Is Produced in Cardiac Fibroblasts and Induces Matrix Metalloproteinases , 2002, Circulation research.
[26] S. Conway,et al. Origin, development, and differentiation of cardiac fibroblasts. , 2014, Journal of molecular and cellular cardiology.
[27] K. Chien,et al. Programming and reprogramming a human heart cell , 2015, The EMBO journal.
[28] Xiaoxia Qi,et al. Heart repair by reprogramming non-myocytes with cardiac transcription factors , 2012, Nature.
[29] J. Burnett,et al. Natriuretic peptides and therapeutic applications , 2007, Heart Failure Reviews.
[30] W. Koch,et al. Dynamic mass redistribution analysis of endogenous β-adrenergic receptor signaling in neonatal rat cardiac fibroblasts , 2014, Pharmacology research & perspectives.
[31] Ivan C. Gerling,et al. Myofibroblast-mediated mechanisms of pathological remodelling of the heart , 2013, Nature Reviews Cardiology.
[32] V. Dzau,et al. Direct reprogramming of cardiac fibroblasts to cardiomyocytes using microRNAs. , 2014, Methods in molecular biology.
[33] Shinsuke Yuasa,et al. Induction of human cardiomyocyte-like cells from fibroblasts by defined factors , 2013, Proceedings of the National Academy of Sciences.
[34] Yanjie Lu,et al. Simvastatin alleviates cardiac fibrosis induced by infarction via up‐regulation of TGF‐β receptor III expression , 2015, British journal of pharmacology.
[35] E. Finch,et al. MicroRNA-Mediated In Vitro and In Vivo Direct Reprogramming of Cardiac Fibroblasts to Cardiomyocytes , 2012, Circulation research.
[36] R. Kalluri,et al. The origin of fibroblasts and mechanism of cardiac fibrosis , 2010, Journal of cellular physiology.
[37] Arjun Deb,et al. Wnt1/βcatenin injury response activates the epicardium and cardiac fibroblasts to promote cardiac repair , 2012, The EMBO journal.
[38] H. Baharvand,et al. Ascorbic acid promotes the direct conversion of mouse fibroblasts into beating cardiomyocytes. , 2015, Biochemical and Biophysical Research Communications - BBRC.
[39] E. Olson,et al. Transient Regenerative Potential of the Neonatal Mouse Heart , 2011, Science.
[40] I. Barthélémy,et al. Cardiac Niche Influences the Direct Reprogramming of Canine Fibroblasts into Cardiomyocyte-Like Cells , 2015, Stem cells international.
[41] W. Blankesteijn,et al. Interventions in Wnt signaling as a novel therapeutic approach to improve myocardial infarct healing , 2012, Fibrogenesis & tissue repair.
[42] J. Rysä,et al. Thrombospondins, potential drug targets for cardiovascular diseases. , 2013, Basic & clinical pharmacology & toxicology.
[43] P. Kohl,et al. Fibroblast-myocyte coupling in the heart: Potential relevance for therapeutic interventions. , 2016, Journal of molecular and cellular cardiology.
[44] Hiroyuki Tsutsui,et al. Fluvastatin, a 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor, Attenuates Left Ventricular Remodeling and Failure After Experimental Myocardial Infarction , 2002, Circulation.
[45] 村岡 直人. MiR-133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures , 2015 .
[46] A. Leask. Potential Therapeutic Targets for Cardiac Fibrosis: TGF&bgr;, Angiotensin, Endothelin, CCN2, and PDGF, Partners in Fibroblast Activation , 2010, Circulation research.
[47] N. Bursac,et al. Transcription Factors MYOCD, SRF, Mesp1 and SMARCD3 Enhance the Cardio-Inducing Effect of GATA4, TBX5, and MEF2C during Direct Cellular Reprogramming , 2013, PloS one.
[48] R. Stewart,et al. Lineage Reprogramming of Fibroblasts into Proliferative Induced Cardiac Progenitor Cells by Defined Factors. , 2016, Cell stem cell.
[49] Milena B. Furtado,et al. Cardiogenic Genes Expressed in Cardiac Fibroblasts Contribute to Heart Development and Repair , 2014, Circulation research.
[50] D. Kass. Cardiac Role of Cyclic-GMP Hydrolyzing Phosphodiesterase Type 5: From Experimental Models to Clinical Trials , 2012, Current Heart Failure Reports.
[51] B. Hinz,et al. The myofibroblast matrix: implications for tissue repair and fibrosis , 2013, The Journal of pathology.
[52] C. I. Spencer,et al. Small molecules enable cardiac reprogramming of mouse fibroblasts with a single factor, Oct4. , 2014, Cell reports.
[53] Cizhong Jiang,et al. Direct reprogramming of mouse fibroblasts into cardiomyocytes with chemical cocktails , 2015, Cell Research.
[54] F. Harrell,et al. Anti‐Remodeling and Anti‐Fibrotic Effects of the Neuregulin‐1β Glial Growth Factor 2 in a Large Animal Model of Heart Failure , 2014, Journal of the American Heart Association.
[55] D. Brenner,et al. Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis. , 2014, The Journal of clinical investigation.
[56] Y. Soini,et al. Thrombospondin-4 expression is rapidly upregulated by cardiac overload. , 2008, Biochemical and biophysical research communications.
[57] Ryan M. Anderson,et al. Primary contribution to zebrafish heart regeneration by gata4+ cardiomyocytes , 2010, Nature.
[58] K. Red-Horse,et al. Developmental Heterogeneity of Cardiac Fibroblasts Does Not Predict Pathological Proliferation and Activation , 2014, Circulation research.
[59] R. Weissleder,et al. Molecular imaging of myocardial infarction. , 2006, Journal of molecular and cellular cardiology.
[60] Stephanie L. K. Bowers,et al. Cardiac Fibroblast: The Renaissance Cell , 2009, Circulation research.
[61] Yao Sun,et al. Platelet-derived growth factor involvement in myocardial remodeling following infarction. , 2011, Journal of molecular and cellular cardiology.
[62] Tevfik F Ismail,et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. , 2013, JAMA.
[63] A. Geinoz,et al. The Fibronectin Domain ED-A Is Crucial for Myofibroblastic Phenotype Induction by Transforming Growth Factor-β1 , 1998, Journal of Cell Biology.
[64] Md. Abul Hassan Samee,et al. Complex Interdependence Regulates Heterotypic Transcription Factor Distribution and Coordinates Cardiogenesis , 2016, Cell.
[65] A. SullengerBruce,et al. RNA-Mediated Reprogramming of Primary Adult Human Dermal Fibroblasts into c-kit+ Cardiac Progenitor Cells , 2015 .
[66] M. Harmsen,et al. Bone marrow‐derived myofibroblasts contribute functionally to scar formation after myocardial infarction , 2008, The Journal of pathology.
[67] B. Sullenger,et al. RNA-Mediated Reprogramming of Primary Adult Human Dermal Fibroblasts into c-kit + Cardiac Progenitor Cells , 2015 .
[68] Greg G. Wang,et al. Bmi1 Is a Key Epigenetic Barrier to Direct Cardiac Reprogramming. , 2016, Cell stem cell.
[69] M. Lindsey,et al. The crossroads of inflammation, fibrosis, and arrhythmia following myocardial infarction. , 2016, Journal of molecular and cellular cardiology.
[70] J. Nerbonne,et al. MicroRNA-133a Protects Against Myocardial Fibrosis and Modulates Electrical Repolarization Without Affecting Hypertrophy in Pressure-Overloaded Adult Hearts , 2010, Circulation research.
[71] Thomas Thum,et al. Noncoding RNAs and myocardial fibrosis , 2014, Nature Reviews Cardiology.
[72] C. Croce,et al. MicroRNA-133 controls cardiac hypertrophy , 2007, Nature Medicine.
[73] B. Aronow,et al. A Thrombospondin-Dependent Pathway for a Protective ER Stress Response , 2012, Cell.
[74] Jimena Canales,et al. Beta(2)-adrenergic receptor regulates cardiac fibroblast autophagy and collagen degradation. , 2011, Biochimica et biophysica acta.
[75] J. Rysä,et al. Thrombospondin-4, tumour necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor Fn14: Novel extracellular matrix modulating factors in cardiac remodelling , 2012, Annals of medicine.
[76] N. Frangogiannis,et al. The inflammatory response in myocardial injury, repair, and remodelling , 2014, Nature Reviews Cardiology.
[77] R. Kalluri,et al. Origins of cardiac fibroblasts. , 2010, Circulation research.
[78] Xueli Yuan,et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis , 2007, Nature Medicine.
[79] D. Srivastava,et al. Recent advances in direct cardiac reprogramming. , 2015, Current opinion in genetics & development.
[80] C. Yin,et al. In vivo cardiac reprogramming using an optimal single polycistronic construct. , 2015, Cardiovascular research.
[81] E. Finch,et al. MicroRNA induced cardiac reprogramming in vivo: evidence for mature cardiac myocytes and improved cardiac function. , 2015, Circulation research.
[82] E. Olson,et al. Macrophages are required for neonatal heart regeneration. , 2014, The Journal of clinical investigation.
[83] A. Lenzi,et al. Phosphodiesterase type 5 inhibitors: back and forward from cardiac indications , 2015, Journal of Endocrinological Investigation.
[84] C. Murry,et al. Regenerating the heart , 2005, Nature Biotechnology.
[85] M. Keating,et al. Heart Regeneration in Zebrafish , 2002, Science.
[86] J. Rysä,et al. (Pro)renin Receptor Triggers Distinct Angiotensin II-Independent Extracellular Matrix Remodeling and Deterioration of Cardiac Function , 2012, PloS one.
[87] R. Ross,et al. Integrins and integrin-related proteins in cardiac fibrosis. , 2016, Journal of molecular and cellular cardiology.
[88] Guofeng Ren,et al. Essential Role of Smad3 in Infarct Healing and in the Pathogenesis of Cardiac Remodeling , 2007, Circulation.
[89] Li Qian,et al. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes , 2011, Nature.
[90] K. Kivirikko,et al. Connective Tissue Growth Factor Inhibition Attenuates Left Ventricular Remodeling and Dysfunction in Pressure Overload–Induced Heart Failure , 2014, Hypertension.
[91] A. Åsberg,et al. Early intervention with a potent endothelin-A/endothelin-B receptor antagonist aggravates left ventricular remodeling after myocardial infarction in rats , 2002, Basic Research in Cardiology.
[92] E. Olson,et al. Akt1/protein kinase B enhances transcriptional reprogramming of fibroblasts to functional cardiomyocytes , 2015, Proceedings of the National Academy of Sciences.
[93] W. Gong,et al. Chronic inhibition of cyclic guanosine monophosphate-specific phosphodiesterase 5 prevented cardiac fibrosis through inhibition of transforming growth factor β-induced Smad signaling , 2014, Frontiers of Medicine.
[94] Xiao-Fan Wang,et al. Smad3 Signaling Critically Regulates Fibroblast Phenotype and Function in Healing Myocardial Infarction , 2010, Circulation research.
[95] D. Theodorescu,et al. Clinical trials with endothelin receptor antagonists: what went wrong and where can we improve? , 2012, Life sciences.
[96] Y. Soini,et al. Divergent Effects of Losartan and Metoprolol on Cardiac Remodeling, C‐kit+ Cells, Proliferation and Apoptosis in the Left Ventricle after Myocardial Infarction , 2009, Clinical and translational science.
[97] M. Ieda,et al. Direct reprogramming of fibroblasts into myocytes to reverse fibrosis. , 2014, Annual review of physiology.
[98] H. Shimokawa,et al. Coronary perivascular fibrosis is associated with impairment of coronary blood flow in patients with non-ischemic heart failure. , 2012, Journal of cardiology.
[99] David Milan,et al. Inefficient Reprogramming of Fibroblasts into Cardiomyocytes Using Gata4, Mef2c, and Tbx5 , 2012, Circulation research.
[100] Maria-Teresa Piccoli,et al. Non-coding RNAs as modulators of the cardiac fibroblast phenotype. , 2016, Journal of molecular and cellular cardiology.
[101] J. Molkentin,et al. Regulation of cardiac hypertrophy by intracellular signalling pathways , 2006, Nature Reviews Molecular Cell Biology.
[102] J. Molkentin,et al. Myofibroblasts: trust your heart and let fate decide. , 2014, Journal of molecular and cellular cardiology.
[103] A. Desmoulière,et al. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts , 1993, The Journal of cell biology.
[104] J. Erler,et al. Matrix cross-linking lysyl oxidases are induced in response to myocardial infarction and promote cardiac dysfunction. , 2016, Cardiovascular research.
[105] J. Rysä,et al. Intramyocardial BNP Gene Delivery Improves Cardiac Function Through Distinct Context-Dependent Mechanisms , 2011, Circulation. Heart failure.
[106] Filipa Pinto,et al. Optimization of direct fibroblast reprogramming to cardiomyocytes using calcium activity as a functional measure of success. , 2013, Journal of molecular and cellular cardiology.
[107] H. Ruskoaho. Atrial natriuretic peptide: synthesis, release, and metabolism. , 1992, Pharmacological reviews.
[108] M. Daemen,et al. The alpha-smooth muscle actin-positive cells in healing human myocardial scars. , 1994, The American journal of pathology.
[109] M. Bader. Tissue renin-angiotensin-aldosterone systems: Targets for pharmacological therapy. , 2010, Annual review of pharmacology and toxicology.
[110] Andrew W. Trafford,et al. Aging and the cardiac collagen matrix: Novel mediators of fibrotic remodelling , 2016, Journal of molecular and cellular cardiology.
[111] N. Frangogiannis. Matricellular proteins in cardiac adaptation and disease. , 2012, Physiological reviews.
[112] Masaki Ieda,et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. , 2010, Cell.
[113] Jae-Bong Park,et al. Neuregulin induces CTGF expression in hypertrophic scarring fibroblasts , 2012, Molecular and Cellular Biochemistry.
[114] C. I. Spencer,et al. Expandable Cardiovascular Progenitor Cells Reprogrammed from Fibroblasts. , 2016, Cell stem cell.
[115] N. Frangogiannis,et al. The pathogenesis of cardiac fibrosis , 2013, Cellular and Molecular Life Sciences.
[116] W. Koch,et al. Inhibition of Let-7 microRNA attenuates myocardial remodeling and improves cardiac function postinfarction in mice , 2014, Pharmacology research & perspectives.
[117] J. C. Belmonte,et al. Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation , 2010, Nature.
[118] M. Watkins. TGF-β activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II–infused mice , 2010 .
[119] J. Epstein,et al. Inhibition of TGFβ Signaling Increases Direct Conversion of Fibroblasts to Induced Cardiomyocytes , 2014, PloS one.
[120] S. Keirstead,et al. Accelerated direct reprogramming of fibroblasts into cardiomyocyte-like cells with the MyoD transactivation domain. , 2013, Cardiovascular research.
[121] Li Qian,et al. Direct Reprogramming of Human Fibroblasts toward a Cardiomyocyte-like State , 2013, Stem cell reports.
[122] S. Heymans,et al. TIMPs and cardiac remodeling: 'Embracing the MMP-independent-side of the family'. , 2010, Journal of molecular and cellular cardiology.
[123] L. Wilkins. Anti‐Remodeling and Anti‐Fibrotic Effects of the Neuregulin‐1β Glial Growth Factor 2 in a Large Animal Model of Heart Failure , 2015, Journal of the American Heart Association.
[124] M. Pucéat,et al. Origins of cardiac fibroblasts. , 2016, Journal of molecular and cellular cardiology.
[125] C. von Kalle,et al. Bone marrow-derived cells contribute to infarct remodelling. , 2006, Cardiovascular research.
[126] E. Olson,et al. Induction of diverse cardiac cell types by reprogramming fibroblasts with cardiac transcription factors , 2014, Development.
[127] S. Pikkarainen,et al. GATA transcription factors in the developing and adult heart. , 2004, Cardiovascular research.
[128] Kenji Nakamura,et al. Cardiac fibrosis in mice lacking brain natriuretic peptide. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[129] R. Henkelman,et al. Electrical remodelling precedes heart failure in an endothelin-1-induced model of cardiomyopathy. , 2011, Cardiovascular research.
[130] F. Prósper,et al. Interacting resident epicardium-derived fibroblasts and recruited bone marrow cells form myocardial infarction scar. , 2015, Journal of the American College of Cardiology.
[131] N. Frangogiannis,et al. The Extracellular Matrix Modulates Fibroblast Phenotype and Function in the Infarcted Myocardium , 2012, Journal of Cardiovascular Translational Research.
[132] S. Rosenkranz. TGF-β1 and angiotensin networking in cardiac remodeling , 2004 .
[133] A. Leask. Potential Therapeutic Targets for Cardiac Fibrosis: TGF&bgr;, Angiotensin, Endothelin, CCN2, and PDGF, Partners in Fibroblast Activation , 2010, Circulation research.
[134] R. Becker,et al. Regeneration of the ventricular myocardium in amphibians , 1974, Nature.
[135] G. Nguyen. Renin, (pro)renin and receptor: an update. , 2011, Clinical science.
[136] Arjun Deb,et al. Cardiac fibroblast in development and wound healing. , 2014, Journal of molecular and cellular cardiology.
[137] A. Cooney,et al. "Triplet" polycistronic vectors encoding Gata4, Mef2c, and Tbx5 enhances postinfarct ventricular functional improvement compared with singlet vectors. , 2014, The Journal of thoracic and cardiovascular surgery.
[138] Gerard Pasterkamp,et al. Lack of Fibronectin-EDA Promotes Survival and Prevents Adverse Remodeling and Heart Function Deterioration After Myocardial Infarction , 2011, Circulation research.
[139] J Michael DiMaio,et al. Making steady progress on direct cardiac reprogramming toward clinical application. , 2013, Circulation research.
[140] Ning Wang,et al. Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines. , 2009, Cardiovascular research.
[141] Peter Kohl,et al. Fibroblast–myocyte electrotonic coupling: Does it occur in native cardiac tissue?☆ , 2014, Journal of molecular and cellular cardiology.
[142] L. A. Bonet,et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2012, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.
[143] Kathryn E. Hentges,et al. The functional diversity of essential genes required for mammalian cardiac development , 2014, Genesis.
[144] Keiichi Fukuda,et al. MiR‐133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures , 2014, The EMBO journal.
[145] E. Small,et al. Transcriptional control of cardiac fibroblast plasticity. , 2016, Journal of molecular and cellular cardiology.
[146] D. Srivastava,et al. Cardiac reprogramming: from mouse toward man. , 2013, Current opinion in genetics & development.
[147] N. Rosenthal,et al. Revisiting Cardiac Cellular Composition. , 2016, Circulation research.
[148] Igor R Efimov,et al. Panoramic imaging reveals basic mechanisms of induction and termination of ventricular tachycardia in rabbit heart with chronic infarction: implications for low-voltage cardioversion. , 2009, Heart rhythm.
[149] Yonggang Ma,et al. Matrix metalloproteinases as input and output signals for post-myocardial infarction remodeling. , 2016, Journal of molecular and cellular cardiology.
[150] JaanaRysä,et al. GATA-4 Is an Angiogenic Survival Factor of the Infarcted Heart , 2010 .
[151] C. Long,et al. Targeting cardiac fibroblasts to treat fibrosis of the heart: focus on HDACs. , 2014, Journal of molecular and cellular cardiology.
[152] I. Dixon,et al. Antifibrotic properties of c-Ski and its regulation of cardiac myofibroblast phenotype and contractility. , 2011, American journal of physiology. Cell physiology.
[153] N. Mercader,et al. Pan-epicardial lineage tracing reveals that epicardium derived cells give rise to myofibroblasts and perivascular cells during zebrafish heart regeneration. , 2012, Developmental biology.
[154] Gianpaolo Zerbini,et al. MiR‐133a regulates collagen 1A1: Potential role of miR‐133a in myocardial fibrosis in angiotensin II‐dependent hypertension , 2012, Journal of cellular physiology.
[155] N. Frangogiannis,et al. Transforming growth factor (TGF)-β signaling in cardiac remodeling. , 2011, Journal of molecular and cellular cardiology.
[156] Thomas K Borg,et al. Determination of cell types and numbers during cardiac development in the neonatal and adult rat and mouse. , 2007, American journal of physiology. Heart and circulatory physiology.